Oligoethylene Phosphoramidate‐Based Kinase Inhibitor Prodrugs – Solubility, Enzyme Inhibition, and Hydrolysis
Chemistry – A European Journal · 2025
DOI: 10.1002/chem.202404618 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2025. Verfasst von Sarah Spiewok und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic and Macromolecular Chemistry, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany. Hauptthemen laut MEDLINE: Prodrugs, Protein Kinase Inhibitors, Amides, Phosphoric Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
The efficiency of kinase inhibiting cancer therapeutics is often limited by their poor solubility in water. PEGylation is one possible strategy to improve the solubility of the drug, however, means to cleave off the PEG after reaching the target is important to make use of the therapeutic effects of the native drug. Moreover, the length of the PEG chains will have an effect on the solubility and binding. In this study, we want to extend our understanding of solubilizing oligo ethylene glycol (OEG) chains connected to kinase inhibitors using a pH labile phosphoramidate linker. We synthesize a library of drug‐OEG conjugates for Ceritinib, Crizotinib, Palbociclib, and Ribocilib kinase inhibitors with n=2, 3, 4 and 8 OEG repeat units. We study the influence on water solubility, enzyme inhibition, and pH induced hydrolysis. A maximum in solubility is obtained for n=3 or 4. We show that small differences in chain length can strongly influence the water solubility, while all other properties remain relatively comparable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Organic and Macromolecular Chemistry, Ulm University, Albert-Einstein-Allee 11, 89081, Ulm, Germany.
ORCID-Profile: Alexander J C Kuehne
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Spiewok, S., Schaefer, M., Lamla, M., Jaritz, Y., & Kuehne, A. J. C. (2025). Oligoethylene Phosphoramidate‐Based Kinase Inhibitor Prodrugs – Solubility, Enzyme Inhibition, and Hydrolysis. Chemistry – A European Journal. https://doi.org/10.1002/chem.202404618
Vancouver
Spiewok S, Schaefer M, Lamla M, Jaritz Y, Kuehne AJC. Oligoethylene Phosphoramidate‐Based Kinase Inhibitor Prodrugs – Solubility, Enzyme Inhibition, and Hydrolysis. Chemistry – A European Journal. 2025. doi:10.1002/chem.202404618
BibTeX
@article{Spiewok2025,
author = {Spiewok, Sarah and Schaefer, Maximilian and Lamla, Markus and Jaritz, Yannick and Kuehne, Alexander J C},
title = {Oligoethylene Phosphoramidate‐Based Kinase Inhibitor Prodrugs – Solubility, Enzyme Inhibition, and Hydrolysis},
journal = {Chemistry – A European Journal},
year = {2025},
doi = {10.1002/chem.202404618}
}
EUVIMED